Gilead Sciences Tops Q3 Earnings And Revenue Estimates

While Gilead has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.